← Evidence map

ArticleJournal of bone metabolism2021

Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab.

Jung-Wee ParkPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34905681